Literature DB >> 7058839

Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response.

C H Fanta, T H Rossing, E R McFadden.   

Abstract

In an effort to determine the optimal emergency therapy for acute episodes of asthma, we randomly, assigned 102 acute ill patients to 60 minutes of treatment with inhaled isoproterenol alone, isoproterenol plus intravenous aminophylline or isoproterenol plus a single oral dose of an elixir of theophylline. Patients requiring treatment beyond this time were given an injectable sympathomimetic agent in addition. The combination of isoproterenol and a methylxanthine was not found to be better than isoproterenol alone, and the route of administration of methylxanthine was not an important determinant of either the serum theophylline level or the therapeutic response. A major variable that influenced the duration of therapy needed to produce a remission was the severity of the obstruction at presentation. Persons whose initial 1-second forced expiratory volumes were less than 30 percent of predicted and who did not improve 35 percent or more to at least 40 percent of predicted at the end of 60 minutes of intense treatment were those who ultimately required prolonged emergency room therapy and/or hospital admission for control of their symptoms. Thus, simple objective assessment of the degree of impairment at presentation coupled with the response to initial treatment will serve to identify early a high-risk group of asthmatic patients in whom the usual emergency room therapeutic modalities will often prove ineffective.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058839     DOI: 10.1016/0002-9343(82)90498-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  Managing asthma in hospital: cause for concern.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

2.  Nebulisers for asthma.

Authors:  M J Ward
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Clinical trials in acute severe asthma: are type II errors important?

Authors:  M J Ward
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

Review 4.  New drugs in respiratory disorders: I.

Authors:  D C Flenley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

Review 5.  Status asthmaticus in adults.

Authors:  H Don
Journal:  Clin Rev Allergy       Date:  1985-02

6.  Pharmacotherapy of asthma.

Authors:  D Sheppard
Journal:  West J Med       Date:  1985-05

Review 7.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

8.  Aminophylline infusion in acute severe asthma: where do we go from here?

Authors:  S R Lloyd; A Sharma
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

Review 9.  Review of acute severe asthma.

Authors:  P K Franklin
Journal:  West J Med       Date:  1989-05

10.  Nebulized salbutamol vs salbutamol and ipratropium combination in asthma.

Authors:  Anita Sharma; Arvind Madaan
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.